. 2023 Mar 17;11(3):e807. doi: 10.1002/iid3.807

Table 2.

Overall summary of literature by vaccine types.

Characteristics	mRNA‐1273	BNT162b2
Characteristics	(Moderna)	(Pfizer−BioNTech)
Total events	444	17,192
Sex
Males	178	8042
Females	193	6102
Unidentified	73	3048
Case management
Colchicine	6	30
NSAIDs^a	7	39
Steroids^b	15	38
ACE inhibitors or ARB^c	4	8
Beta blockers^d	6	13
Anticoagulant & Xa inhibitors^e	5	13
Antiplatelet^f	0	3
Platelet transfusion	4	15
IVIG	10	30
Diuretics^g	3	4
Mean time between vaccine and symptom onset (days)	5.6	4.8
Mean length of hospitalization (days)	3.7	6.0
Mortality (n)^h	56	228
Laboratory findings (n with highest values)
d‐Dimer level >500 (ng/mL)	5	12
CK‐MB (ng/mL)	0	9
Troponin‐I	8	27
Troponin‐T	5	21
CRP levels >10 mg/L	13	50
ECG findings
ST elevation	16	70
ST depression	1	7
PR depression	7	10
T‐wave abnormality	2	17
Bundle branch block	1	2
Sinus tachycardia	2	9

Abbreviation: ECG, electrocardiogram.

^{^a}

NSAIDs used in treatment include ibuprofen, aspirin, acetylsalicylic acid, ketorolac.

^{^b}

Steroids listed: corticosterone, prednisone, methylprednisolone, dexamethasone.

^{^c}

ARB/ACE inhibitors: lisinopril, ramipril, candesartan.

^{^d}

Beta blockers: bisoprolol, metoprolol, carvedilol.

^{^e}

Anticogulants/Xa inhibitors: rivaroxaban, apixaban, warfarin, enoxaparin, heparin, clexane dabigatran, lovenox.

^{^f}

Antiplateletes: clopidogrel, eptifibatide, ticagrelor.

^{^g}

Diuretics: acetazolamide, furosemide, mineralocorticoid antagonist.

^{^h}

n = 2 vaccine types unspecified.